Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

More documents

Recommendations

Info

136Annual Report on Lymphatic Filariasis 20033.3.4 What is the national geographical coverage of MDA? ……………………………………………………………...………(Number of IUs under mass drug administration/total number of endemic IUs in country x 100)3.3.5 How many IUs reported MDA to the national PELF with coverage data? ………….........................……..........ANNEXES Annex 2 Revised Annual Report Form
1373.3.6a Report of MDA coverage by IUsRegion Name of IU MDAtypeMDA period Details of IUData reported by IUStartdateEnddateNo. ofvillagesin IUTotal pop. in villages a No. ofurbanareas inIUTotalpop. inurbanareasin IUTotal pop. of IU a Eligible pop. of IU b No. of poplewhodrugs b pop. pop. covered areas villages urban(%) cingested % of No. of % of drugs d drugs fingested ingestedin IU in IU g coveredthe total eligible villages urban total totalwho who in IU covered covered areasthe thein IU he e.g. 80[65—95%]TOTALaFor calculation of overall coverage, use the total population as denominator. Census data or estimates of total population enumerated by drug distributors can be used.bIn areas where DEC and albendazole are administered, the eligible population = total population minus pregnant women, children under 2 years and the severely ill. In areas where ivermectin and albendazoleare administered, the eligible population = total population minus pregnant women, women in the first week of lactation, children under 90 cm or 15 kg, and the severely ill.cDrug coverage is calculated as a percentage of the total population as well as of the eligible population who ingested the drugs. This coverage is evaluated by year and by MDA period. It can be calculated foreach IU from reports received from reporting units or drug distributors.dNo. of people who ingested the drugs/total population in IU x 100.eCountry coverage reported (% of variation of coverage): give in brackets the minimal and maximal coverage reported in the IU.fNo. of people who ingested the drugs/eligible population in IU x 100.gNo. of villages covered/no. of villages in IU x 100.hNo. of urban areas covered/no. of urban areas in IU x 100.ANNEXES Annex 2 Revised Annual Report FormAnnual Report on Lymphatic Filariasis 2003
Page 1 and 2:
For further information about lymph
Page 3:
WHO/CDS/CPE/CEE/2005.52GlobalProgra
Page 7 and 8:
3Report of the Technical Advisory G
Page 9 and 10:
P R O G R A M M E H I G H L I G H T
Page 11:
I N T R O D U C T I O N7This Annual
Page 14 and 15:
10Annual Report on Lymphatic Filari
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
38Figure 3.2 Outcomes and planning
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 59 and 60:
UNITED REPUBLIC OF TANZANIA55Endemi
Page 61 and 62:
ZANZIBAR, UNITED REPUBLIC OF TANZAN
Page 63:
59AMERICAN PROGRAMME REVIEWGROUPAt
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
82Figure 3.100 Outcomes and plannin
Page 88 and 89:
Page 90 and 91: 86Annual Report on Lymphatic Filari
Page 92 and 93: 88Figure 3.118 Outcomes and plannin
Page 94 and 95: 90Figure 3.124 Outcomes and plannin
Page 104 and 105: 100Annual Report on Lymphatic Filar
Page 118 and 119: 114Figure 3.196 Outcomes and planni
Page 127: C H A P T E R 6FURTHER DOCUMENTATIO
Page 135 and 136: ANNUAL REPORT FOR THE NATIONAL PROG
Page 137 and 138: 1332. PROGRAMME RESOURCES2.1 Please
Page 139: 1353.3 Interruption of transmission
Page 143 and 144: 1393.3.7 Surveys in sentinel sites
Page 145 and 146: 1413.3.10 Please attach a map of th
Page 147 and 148: 1434. SERIOUS ADVERSE EXPERIENCES (
Page 149 and 150: A N N E X E SANNEX 3: LIST OF LF-EN
Page 151 and 152: 147RAPLOARPRGSAESEAROTAG-LFTDRUNDPU
Page 153 and 154: 149Drug administration and monitori
show all

Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

Create successful ePaper yourself

Delete template?

Save as template?